Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Biosimilars Market to reach USD 68.34 Billion by 2028.

Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028

Product Code: HLSDT-14863184
Publish Date: 22-04-2022
Page: 200

Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 23.5% over the forecast period 2022-2028. A biosimilar is a biologic medical item that is a homogenous copy of an original item, which is produced by a further organization. Biosimilars are legitimately permitted varieties of original innovator products and can be produced when the original product’s patent expires. The increasing geriatric population and the growing prevalence of chronic diseases, escalating demand for biosimilar drugs owing to its cost-effectiveness, as well as abbreviated regulatory approval process and concept of interchangeability are the chief driving factors for the market demand across the globe. For instance, Biocon Biologics in partnership with Viatris, Inc. received the approval of the FDA In July 2021 for the world’s first interchangeable biosimilar SEMGLEE (insulin glargine-yfgn injection) that is used for the treatment of diabetes. However, complexities in manufacturing impede the growth of the market over the forecast period of 2022-2028. Also, increasing investment in the research for the introduction of new indications is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Biosimilars market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing incidence of chronic disorders and the introduction of new biosimilars. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing population, as well as the emergence of new players and early entry into the market, would create lucrative growth prospects for the Biosimilars market across the Asia-Pacific region.

Major market players included in this report are:
Samsung Biologics
Intas Pharmaceuticals Ltd.
Reliance Life Sciences
Pfizer, Inc.
Coherus BioSciences
Dr. Reddy’s Laboratories Ltd.
Amgen, Inc.
Biocon Limited
Apotex, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Monoclonal Antibodies
Granulocyte Colony-Stimulating Factor
Recombinant Human Growth Hormone
Enoxaparin Sodium
By Indication
Inflammatory & Autoimmune Disorders
Chronic Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Indications
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019,2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Biosimilars Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Biosimilars Market, by Region, 2020-2028(USD Billion)
1.2.2. Biosimilars Market, by Product, 2020-2028(USD Billion)
1.2.3. Biosimilars Market, by Indication, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biosimilars Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biosimilars Market Dynamics
3.1. Biosimilars Market Impact Analysis (2020-2028)
3.1.1. Market Drivers Increasing geriatric population and the growing incidence of chronic diseases Increasing demand for biosimilar drugs
3.1.2. Market Challenges Complexities in manufacturing
3.1.3. Market Opportunities Increasing investment for the introduction of new indications
Chapter 4. Global Biosimilars Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Biosimilars Market, by Product
6.1. Market Snapshot
6.2. Global Biosimilars Market by Product, Performance – Potential Analysis
6.3. Global Biosimilars Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
6.4. Biosimilars Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Insulin
6.4.3. Granulocyte Colony-Stimulating Factor
6.4.4. Erythropoietin
6.4.5. Recombinant Human Growth Hormone
6.4.6. Etanercept
6.4.7. Follitropin
6.4.8. Teriparatide
6.4.9. Interferons
6.4.10. Enoxaparin Sodium
6.4.11. Glucagon
6.4.12. Calcitonin
Chapter 7. Global Biosimilars Market, by Indication
7.1. Market Snapshot
7.2. Global Biosimilars Market by Indication, Performance – Potential Analysis
7.3. Global Biosimilars Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
7.4. Biosimilars Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Inflammatory & Autoimmune Disorders
7.4.3. Chronic Diseases
7.4.4. Blood Disorders
7.4.5. Growth Hormone Deficiency
7.4.6. Infectious Diseases
7.4.7. Other Indications
Chapter 8. Global Biosimilars Market, Regional Analysis
8.1. Biosimilars Market, Regional Market Snapshot
8.2. North America Biosimilars Market
8.2.1. U.S. Biosimilars Market Product breakdown estimates & forecasts, 2019-2028 Indication breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Biosimilars Market
8.3. Europe Biosimilars Market Snapshot
8.3.1. U.K. Biosimilars Market
8.3.2. Germany Biosimilars Market
8.3.3. France Biosimilars Market
8.3.4. Spain Biosimilars Market
8.3.5. Italy Biosimilars Market
8.3.6. Rest of Europe Biosimilars Market
8.4. Asia-Pacific Biosimilars Market Snapshot
8.4.1. China Biosimilars Market
8.4.2. India Biosimilars Market
8.4.3. Japan Biosimilars Market
8.4.4. Australia Biosimilars Market
8.4.5. South Korea Biosimilars Market
8.4.6. Rest of Asia Pacific Biosimilars Market
8.5. Latin America Biosimilars Market Snapshot
8.5.1. Brazil Biosimilars Market
8.5.2. Mexico Biosimilars Market
8.6. Rest of The World Biosimilars Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Samsung Biologics Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. Intas Pharmaceuticals Ltd.
9.2.3. Celltrion
9.2.4. Reliance Life Sciences
9.2.5. Pfizer, Inc.
9.2.6. Coherus BioSciences
9.2.7. Dr. Reddy’s Laboratories Ltd.
9.2.8. Amgen, Inc.
9.2.9. Biocon Limited
9.2.10. Apotex, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now